CN103372044A - Medicament for treating hemicranias, and application thereof in preparation of nose drop for treating hemicranias - Google Patents
Medicament for treating hemicranias, and application thereof in preparation of nose drop for treating hemicranias Download PDFInfo
- Publication number
- CN103372044A CN103372044A CN 201210110610 CN201210110610A CN103372044A CN 103372044 A CN103372044 A CN 103372044A CN 201210110610 CN201210110610 CN 201210110610 CN 201210110610 A CN201210110610 A CN 201210110610A CN 103372044 A CN103372044 A CN 103372044A
- Authority
- CN
- China
- Prior art keywords
- hemicranias
- treating
- medicament
- migraine
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a medicament for treating hemicranias, and application thereof in preparation of a nose drop for treating the hemicranias relating to the medicament for treating the hemicranias, particularly relates to a medicament containing raw white turnip juice for treating the hemicranias, and application of the raw white turnip juice in preparation of the nose drop for treating the hemicranias, and belongs to the field of a medicine. The first target of the invention is to provide the medicament, which has the effect of relieving the hemicranias, and is free of side effect and low in cost; the second target of the invention is to provide new use of the raw white turnip juice. In order to achieve the targets of the invention, the invention adopts the following technical scheme: the medicament is characterized by comprising the raw white turnip juice; a pharmaceutical acceptable carrier is added. The application of the medicament in preparation of the nose drop for treating the hemicranias is characterized in application of the raw white turnip juice in the medicament for treating the hemicranias.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of migraine, specifically, relates to a kind of medicine that contains the treatment migraine of living juice of white turnip, and gives birth to the application of juice of white turnip in preparation treatment migraine nasal drop.Belong to field of medicaments.
Background technology
Migraine is a kind of pulsatile headache of repeatedly showing effect, and belongs to " rich and influential family " in numerous headache types.The tendencys such as flash of light, blurred vision, numb limbs and tense tendons are often arranged before the outbreak, simultaneously can be with neural, mental function disorder.It is a kind of disease that can progressively worsen, and frequency of disease development is usually more and more higher.
Migraine is divided into following five kinds.
(1) do not accompany the migraine (general type migraine) of tendency the most common.Ictal moderate is to the severe pulsatile headache, and the companion feels sick, vomiting or photophobia.Physical exertion makes the headache aggravation.Only be light dull pain or sense of discomfort to moderate during the outbreak beginning, reach serious throbbing pain or jumping pain after a few minutes to several hours.About 2/3 is a side headache, also can be bilatenal headache, and pain is radiated to cervical region and shoulder sometimes.Headache continues 4～72 hours, common alleviation after the sleep.The clear and definite normal clearance phase is arranged between outbreak.If the closely related title Menstrual migraine of 90% outbreak and menstrual cycle.Above-mentioned outbreak 5 times appear at least, except can make diagnosis after the outer various organic diseases of intracranial.
(2) migraine (classical migraine) with tendency can be divided into tendency and two phases of headache.
Tendency phase visual symptoms is the most common, and such as photophobia, defect of visual field, dim spot, hemianopsia or temporary blindness appear in aethomma, spark, or complicated visual hallucination then.Hemianesthesia, slight hemiplegia or speech disorder can appear in a few patients.Tendency continues 5～20 minutes mostly.
The headache phase is everlasting and occurs when tendency begins to disappear.Pain starts from the side socket of the eye more, temple, and socket of the eye rear portion or volume temporo district increase the weight of to extend to half side head gradually, even whole head and cervical region.Headache is jumping pain or Drilling sample for pulsation, and degree increases the weight of to develop into persistence severe pain gradually.Normal companion feels sick, vomiting, photophobia, phonophobia.The patient's flush that has, the conjunctival congestion of perspiring in a large number; The patient's pale complexion that has, lethargy, anorexia.Once showed effect sustainable 1～3 day, and usually had a headache after the sleep and obviously alleviate, but the later continuous a few days lassitude of outbreak.The outbreak intermission, all were normal.
Above-mentioned classical migraine can be divided into several hypotypes.
(1) with the migraine of typical tendency: comprise ocular migraine, hemiplegia type migraine, aphasia type migraine etc.At least 2 above-mentioned typical case outbreaks occurred, and diagnosed and to set up after getting rid of organic illness.
(2) with the migraine (complexity migraine) that prolongs tendency: symptom is with (1).Tendency still exists lastingly in the headache episode process, and duration is above 1 hour and less than 1 week.The neuroimaging inspection can not have been found the Intracranial structure disease damage.
(3) base type migraine (former title basilar artery migraine): the premonitory symptom that clearly originates from brain stem or bilateral occipital lobe is arranged, and the visual symptoms that has such as blind, eyes migraine temporo side and nasal visual field, dysarthria, dizzy, tinnitus, auditory dysesthesia, diplopia, ataxia, bilateral be sexy feels unusual, bilateral paresis or mental disorder etc.How in several minutes to 1 hour, to disappear, then find bilateral occipital region pulsatile headache.The gap phase, all were normal.
(4) migraine aura of companioned with headache (outbreak of migraine equipotential) not: the various premonitory symptoms of migraine occur seeing, but headache do not occur subsequently if having time.When patient age gradually old, but headache complete obiteration and ictal premonitory symptom is still arranged, but it is then less to show as premonitory symptom no headache person fully.The First episode person need do testing in depth testing after 40 years old, except thromboembolia type TIA.
(3) ophthalmoplegic migraine is seldom seen.Onset is older many below 30 years old.The headache history of attack that is fixed in a side is arranged, after once than severe headache (pain behind eye socket or the socket of the eye) outbreak, the ophthalmoplegia of homonymy occurs, above blepharoptosis is the most common.Paralysis continues to recover after a few days or several weeks.Beginning several times morbidity paralysis recovers fully, but repeatedly can leave over ophthalmoplegia partialis after the outbreak and do not recover.The neuroimaging not Song typeface is got rid of the organic disease damage of intracranial.
(4) the benign paroxysmal vertigo childhood period (outbreak of migraine equipotential) has the migraine family history but child's no headache.Show as repeatedly, of short duration onset of vertigo, also ictal dysequilibrium, anxiety can appear, with nystagmus or vomiting.Nervous system and EEG (electrocardiogram) examination are normal.The gap phase, all were normal.Among Children can transfer migraine to after growing up.
(5) the statural hemicranicus migraine persistent period is at the title statural hemicranicus that (may have therebetween and be shorter than 4 hours catabasis) more than 72 hours.
It is very painful to suffer from the patient, and does not also have a kind of medicine of energy rapid recovery migraine at present.
Summary of the invention
One of goal of the invention of the present invention is to provide a kind of and have the alleviation migraine, and have no side effect, medicine with low cost.
Two of goal of the invention is that a kind of new purposes of giving birth to juice of white turnip is provided.
For reaching above-mentioned purpose of the present invention, the present invention adopts following technical scheme, the invention is characterized in: comprise living juice of white turnip, and add pharmaceutically acceptable carrier.
The application of this medicine that the present invention provides in preparation treatment migraine nasal drop is characterized in that: give birth to the application of juice of white turnip in treatment migraine medicine.
Beneficial effect of the present invention.
The present invention adopts living juice of white turnip as the main material for the treatment of migraine medicine, and is easy to prepare, with low cost.
And it is without any side effects to give birth to juice of white turnip; And can alleviate fast migraine.
The specific embodiment
The invention is characterized in: comprise living juice of white turnip, and add pharmaceutically acceptable carrier.
The application of this medicine that the present invention provides in preparation treatment migraine nasal drop is characterized in that: give birth to the application of juice of white turnip in treatment migraine medicine.
When the present invention uses, directly splash into nasal cavity and can in 10 minutes, alleviate migraine giving birth to liquid medicine that juice of white turnip makes.
After using the present invention, the migraine of which kind of type no matter; All can be eased.Make the migraine patient cross normal life.
Claims (2)
1. treat migrainous medicine and the application of this medicine in preparation treatment migraine nasal drop for one kind, it is characterized in that: comprise living juice of white turnip, and add pharmaceutically acceptable carrier.
2. a kind of treat migrainous medicine and the application of this medicine in preparation treatment migraine nasal drop according to claim 1 is characterized in that: give birth to the application of juice of white turnip in treatment migraine medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210110610 CN103372044A (en) | 2012-04-16 | 2012-04-16 | Medicament for treating hemicranias, and application thereof in preparation of nose drop for treating hemicranias |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210110610 CN103372044A (en) | 2012-04-16 | 2012-04-16 | Medicament for treating hemicranias, and application thereof in preparation of nose drop for treating hemicranias |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103372044A true CN103372044A (en) | 2013-10-30 |
Family
ID=49458291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210110610 Pending CN103372044A (en) | 2012-04-16 | 2012-04-16 | Medicament for treating hemicranias, and application thereof in preparation of nose drop for treating hemicranias |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103372044A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103599155A (en) * | 2013-11-27 | 2014-02-26 | 广州安健实业发展有限公司 | Novel method for treating migraine |
-
2012
- 2012-04-16 CN CN 201210110610 patent/CN103372044A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103599155A (en) * | 2013-11-27 | 2014-02-26 | 广州安健实业发展有限公司 | Novel method for treating migraine |
| CN104922127A (en) * | 2013-11-27 | 2015-09-23 | 广州安健实业发展有限公司 | Method for treating migraine |
| CN103599155B (en) * | 2013-11-27 | 2015-12-02 | 广州安健实业发展有限公司 | Treat migrainous method |
| CN104922127B (en) * | 2013-11-27 | 2016-11-30 | 广州安健实业发展有限公司 | Formula 2 compound purposes in the medicine of preparation treatment and/or prevention of migraine and complication thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102631558B (en) | Medicament for treating eye disease and preparation method of medicament | |
| Ping et al. | Clinical observation on post-stroke anxiety neurosis treated by acupuncture | |
| CN103372044A (en) | Medicament for treating hemicranias, and application thereof in preparation of nose drop for treating hemicranias | |
| CN101961442A (en) | Ointment for treating skin scars | |
| CN110522777A (en) | A kind of antiepileptic action of Bupleurum chinense DC difference extract | |
| Garcia-Catalan et al. | Charles Bonnet syndrome precipitated by brimonidine | |
| CN101797314B (en) | Medicinal composition for treating adolescent myopia and preparation method thereof | |
| CN104258023B (en) | Traditional Chinese medicine composition for treating depressive disorder | |
| CN101623404B (en) | Traditional Chinese medicine composition for treating primary trigeminal neuralgia | |
| CN104815176B (en) | A kind of preparation method for the treatment of the medicine of apoplexy sequela | |
| WO2019096144A1 (en) | Use of pientzhuang and preparation thereof in treatment of cerebral stroke sequelae | |
| CN103585345B (en) | A kind of pharmaceutical composition being used for the treatment of herpes zoster and post herpetic neuralgia thereof | |
| CN103705748B (en) | A kind of medicament for the treatment of shoulder-hand syndrome | |
| CN101884701B (en) | Medicament for treating herpes zoster | |
| Cheema et al. | A case of tri-segmental cranial nerve V herpes zoster | |
| Hassan et al. | Propranolol in treatment of huge and complicated infantile hemangiomas in egyptian children | |
| CN101947269B (en) | Medicine for treating viral herpes | |
| CN105853453A (en) | Application of baicalin in preparation of medicine for protecting heart development of fetus with pregnancy associated with diabetes | |
| Zhang et al. | The clinical efficacy and safety of edaravone combined with GM1 in the treatment of the elderly patients with cerebral infarction | |
| CN104000819B (en) | A kind of therapeutic combination promoting Patients with Cerebral Infarction neuranagenesis | |
| CN104069261A (en) | Traditional Chinese medicine preparation for treating Meniere's disease | |
| CN105435137A (en) | A traditional Chinese medicine preparation for treating trigeminal neuralgia | |
| CN104721390B (en) | A kind of medicine for the treatment of infantile viral myocarditis | |
| Qin et al. | Effect of early rehabilitation nursing intervention on the recovery of cognitive function in patients with craniocerebral trauma | |
| CN103340949B (en) | Eye drops for removing nebula and cataract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20131030 |